Rare diseases are typically caused by genetic mutations that prevent normal bodily functions and are often difficult to diagnose due to the small number of individuals affected by them. Genetic testing for rare diseases can be pre-symptomatic, meaning it can detect the mutation before symptoms appear, or it can be diagnostic, used to confirm a clinical diagnosis. The process of rare disease genetic testing often involves the collection of a blood, 唾液, or tissue sample, which is then analyzed using specialized laboratory techniques such as DNA sequencing, chromosomal microarray analysis, and other genetic testing methods. These tests can help identify genetic changes that may be associated with the specific rare disease. Rare disease genetic testing can also provide information on a person’s carrier status, which indicates whether they carry a mutation for a rare disease but do not show any symptoms. This information can be useful for family planning purposes, helping individuals understand the risk of passing on a rare disease to their children. 根据最新的市场研究结果, the global rare disease genetic testing market stood at around USD 918.0 百万 2022 预计将升至美元价值 1,727.2 百万 2029 结尾, 从而获得了复合年增长率 9.45% 期间 2023-2029.

该报告涵盖了市场规模和增长, 分割, 区域细分, 竞争格局, trends and strategies for global rare disease genetic testing market. 它提供了对市场的定量分析，使利益相关者能够利用当前的市场机会. 该报告还根据市场趋势和主要竞争对手的方法确定了最重要的机会和战略细分市场.

该行业报告提供了全球市场的市场估计和预测, followed by a detailed analysis of the disease type, 技术, specialty, 最终用户, 和地区. The global market for rare disease genetic testing can be segmented by disease type: immunological disorders, cardiovascular disorders, neurology disease, endocrine and metabolism disorders diseases, hematology diseases, dermatology disease, 其他的. The neurology disease segment held the largest share of the global rare disease genetic testing market in 2022 预计在预测期内将持有其份额. Rare disease genetic testing market is further segmented by technology: 下一代测序, 桑格测序, PCR based testing, array based testing, FISH, 其他的. 全球范围, the next generation sequencing segment made up the largest share of the rare disease genetic testing market. Based on specialty, the rare disease genetic testing market is segmented into: molecular genetic tests, chromosomal genetic tests, biochemical genetic tests. The molecular genetic tests segment was the largest contributor to the global rare disease genetic testing market in 2022. 基于最终用户, the rare disease genetic testing market also can be divided into: 医院 & 诊所, research laboratories & 合同研究组织, 诊断实验室, 其他的. The research laboratories & CROs segment is estimated to account for the largest share of the global rare disease genetic testing market. Rare disease genetic testing market by region is categorized into: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美.

市场细分
By disease type: immunological disorders, cardiovascular disorders, neurology disease, endocrine and metabolism disorders diseases, hematology diseases, dermatology disease, 其他的
按技术: 下一代测序, 桑格测序, PCR based testing, array based testing, FISH, 其他的
By specialty: molecular genetic tests, chromosomal genetic tests, biochemical genetic tests
按最终用户: 医院 & 诊所, research laboratories & 合同研究组织, 诊断实验室, 其他的
按地区: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美

The global rare disease genetic testing market report offers detailed information on several market vendors, including Associated Regional and University Pathologists, 公司, Centogene NV, Eurofins Scientific SE, Fulgent Genetics Inc., OPKO Health, 公司, 珀金埃尔默公司, Quest Diagnostics Incorporated, 除其他外. 在这份报告中, 全面分析关键参与者及其策略，以了解市场的竞争前景.
*索取免费样品以获得完整的公司列表

报告范围
• To analyze and forecast the market size of the global rare disease genetic testing market.
• To classify and forecast the global rare disease genetic testing market based on disease type, 技术, specialty, 最终用户, 地区.
• To identify drivers and challenges for the global rare disease genetic testing market.
• 检查竞争性发展，例如合并 & 收购, 协议, 合作与伙伴关系, ETC。, in the global rare disease genetic testing market.
• To identify and analyze the profile of leading players operating in the global rare disease genetic testing market.

为什么选择这份报告
• Gain a reliable outlook of the global rare disease genetic testing market forecasts from 2023 到 2029 跨场景.
• 确定投资的增长领域.
• 通过公司简介和市场数据保持领先于竞争对手.
• 以 Excel 格式进行跨场景分析的市场预估.
• 三个月的战略咨询和研究支持.
• 为单用户许可证提供打印验证.